Walbert Keli
Insider CIK 2051489 · APLS Director · SPRB Director · COAG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holding | A Award deriv | 2026-09-24 | 2026-09-25 | 36,000 | — | $0 | 36,000 | SEC↗ |
| COAG Hemab Therapeutics Holding | A Award deriv | 2026-09-24 | 2026-09-25 | 36,000 | — | $0 | 36,000 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 14,684 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 15,388 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 8,332 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 664 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 7,297 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | U Tender | 2026-05-14 | 2026-05-14 | 17,051 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2026-01-01 | 2026-01-05 | 14,684 | — | $0 | 14,684 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2026-01-01 | 2026-01-05 | 7,961 | — | $0 | 17,051 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 3,400 | — | $0 | 3,400 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2025-01-08 | 2025-01-10 | 15,388 | $33.00 | $507.8K | 15,388 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2025-01-08 | 2025-01-10 | 9,090 | — | $0 | 9,090 | SEC↗ |